Innospec Files 8-K for Financial Results and Exhibits

Ticker: IOSP · Form: 8-K · Filed: Feb 14, 2024 · CIK: 1054905

Sentiment: neutral

Topics: financial-results, 8-K filing, disclosure

TL;DR

**Innospec just filed an 8-K for their financial results, expect more details soon.**

AI Summary

INNOSPEC INC. filed an 8-K on February 14, 2024, reporting an event that occurred on February 13, 2024. This filing pertains to the company's results of operations and financial condition, along with related financial statements and exhibits. The document indicates a routine disclosure of financial information, though specific dollar amounts are not detailed in this snippet.

Why It Matters

This 8-K signals that INNOSPEC INC. is disclosing its latest financial performance, which is crucial for investors to assess the company's health and make informed decisions. It provides transparency into the company's operational results.

Risk Assessment

Risk Level: medium — While the filing itself is a routine disclosure, the actual financial results it contains could significantly impact the company's stock price and investor sentiment.

Key Numbers

Key Players & Entities

FAQ

What is the purpose of this 8-K filing by INNOSPEC INC.?

This 8-K filing by INNOSPEC INC. is for "Results of Operations and Financial Condition" and "Financial Statements and Exhibits."

When was the earliest event reported in this 8-K?

The earliest event reported in this 8-K occurred on February 13, 2024.

What is the filing date of this 8-K?

The 8-K was filed as of February 14, 2024.

What is INNOSPEC INC.'s state of incorporation?

INNOSPEC INC. is incorporated in Delaware.

What is the business address of INNOSPEC INC. as listed in the filing?

The business address is 8310 South Valley Highway, Suite 350, Englewood, Colorado, 80112.

Filing Stats: 435 words · 2 min read · ~1 pages · Grade level 11 · Accepted 2024-02-14 06:08:32

Filing Documents

Financial Statements and Exhibits

Financial Statements and Exhibits. (d)Exhibits. EXHIBIT INDEX Number Description Method of Filing 99.1 Press Release dated February 13, 2024 announcing Innospec Inc.'s financial results for the fiscal year ended December 31, 2023. Filed Herewith 104 Cover Page Interactive Data File – the cover page XBRL tags are embedded within the Inline XBRL document.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INNOSPEC INC. Date: February 14, 2024 By: /s/ David B. Jones David B. Jones Senior Vice President, General Counsel and Chief Compliance Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing